Sector: Pharmaceuticals & Biotechnology

Large Cap

Wockhardt Share Price

WOCKPHARMA

₹1,812.80

-18.50(-1.01%)

10th Jul 2026 | 3:28 PM

NSE : WOCKPHARMA

Open Free Demat Account

Wockhardt Performance

Price Movement

₹1812.80

₹1798.40

₹1850.40

↘ Today's Low↗ Today's High

1 Year Performance

₹1812.80

₹1086.70

₹2422.30

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹1,850.40

Low₹1,798.40

Open at₹1,850.00

Prev Close₹1,831.30

Volumes6.33 L

Avg Price₹1,818.42

Lower Circuit₹1,465.10

Upper Circuit₹2,197.50

Historical Performance

3M High₹2,422.30

3M Low₹1,307.50

1 Yr High₹2,422.30

1 Yr Low₹1,086.70

3 Yr High₹2,422.30

3 Yr Low₹213.25

5 Yr High₹2,422.30

5 Yr Low₹145.15

Summary

As of 10-07-2026 20:22, Wockhardt Ltd. share price today is ₹0, with a change of ₹-1831.30 (-100.00%) from the previous close of ₹1831.3. The stock opened at ₹1850 and traded between ₹1798.4 and ₹1850.4, with a total traded volume of 632786 shares. The company has a market capitalization of ₹29757.2 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹2422.3 and ₹1086.7, respectively.

Wockhardt Ltd. valuation metrics include a P/E ratio of 139.7, EPS of ₹13.12, and book value of ₹6.00. Profitability indicators show ROE of 4.31%. Wockhardt Ltd. has reported revenue of ₹3373 Cr and net profit of ₹213 Cr.

Wockhardt Ltd. technical indicators include Day RSI at 43.58, Day MFI at 24.83, Day ADX at 25.02. Additional indicators include Commodity Channel Index (CCI) at -168.4 and Williams %R at -92.27. Momentum indicators show Day MACD at 13.66, Day MACD Signal Line at 43.98, DayATR at 83.26. Rate of Change indicators for Wockhardt Ltd. include ROC125 at 30.23 and ROC21 at -2.98.

Exponential moving averages include EMA5 at ₹1865.6, EMA10 at ₹1897.7, EMA12 at ₹1904.2, EMA20 at ₹1905.5, EMA26 at ₹1890.5, EMA50 at ₹1797.4, EMA100 at ₹1658.3, EMA200 at ₹1543.3. Simple moving averages include SMA5 at ₹1873.4, SMA10 at ₹1913.6, SMA20 at ₹1942, SMA30 at ₹1948.1, SMA50 at ₹1794.8, SMA100 at ₹1557.5, SMA150 at ₹1501.6, SMA200 at ₹1472.1.

Support levels for Wockhardt are placed at First Support ₹1810.90, Second Support ₹1790.50, Third Support ₹1759.00. Resistance levels are seen at First Resistance ₹1862.80, Second Resistance ₹1894.30, Third Resistance ₹1914.70. Wockhardt Ltd. shareholding pattern shows promoter holding at 49.08%, FII holding at 7.09%, DII holding at 0%, public holding at 32.84%.

Wockhardt Fundamentals

Market Cap

High in industry

29,757.20 Cr.

PE Ratio (TTM)

High in industry

139.70

Dividend Yield

Net Profit TTM

553.2% incr over last year

213

Net Profit Growth

553.2% incr over last year

213

PEG Ratio

Above industry Median

0.30

ROE

502.8% incr over last year

4.31

Operating Revenue TTM

3,373

Operating Revenue Growth

12.0% incr over last year

Book Value

Above industry Median

MFI

MFI oversold

24.83

RSI

RSI is mid-range

43.58

EPS (TTM)

13.12

Debt to Equity

0.43

Face Value

Operating Profit Margin Qtr.

18.71

Operating Profit Qtr.

225

Net Profit Qtr.

166

Operating Revenue Qtr.

965

PB Ratio

Wockhardt Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	516	430	380	413	355
Operating Expense	355	317	267	282	249
Operating Profit	161	113	113	131	106
Depreciation	43	52	45	46	40
Interest	41	50	44	41	40
Tax	0	0	0	0	0
Net Profit	167	28	54	69	40

Wockhardt Technicals

Wockhardt Ltd. EMA & SMA

₹1812.80

-11.70 (-0.64%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1865.6

Day EMA10 ₹1897.7

Day EMA12 ₹1904.2

Day EMA20 ₹1905.5

Day EMA26 ₹1890.5

Day EMA50 ₹1797.4

Day EMA100 ₹1658.3

Day EMA200 ₹1543.3

Wockhardt Support and Resistance

Resistance

First Resistance₹1862.80

Second Resistance₹1894.30

Third Resistance₹1914.70

Support

First Support₹1810.90

Second Support₹1790.50

Third Support₹1759.00

Technical Indicators

Day RSI43.58

Day MFI24.83

Day ADX25.02

Day Commodity Channel Index-168.40

William-92.27

Day MACD13.66

Day MACD Signal Line43.98

Day ATR83.26

Day ROC12530.23

Day ROC21-2.98

Wockhardt Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	49.1	49.1	49.1	49.1	49.1	49.1
FII	6.5	6.8	7.3	7.1	7	7.1
DII	9.9	10.6	11	11	10.6	11
Public	34.5	33.5	32.6	32.8	33.4	32.8

Wockhardt Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	2.41 L	6.06 L	39.71%
Week	2.6 L	6.29 L	41.36%
1 Month	4.04 L	12.81 L	31.55%
6 Month	4.09 L	15.96 L	25.61%

Wockhardt SWOT Analysis

Strengths22

Weakness9

Opportunity2

Threats0

Benjamin Graham Value Screen

Strong Performer, Getting Expensive (DVM)

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with 10% increase in share price over three months, with rising net profit growth

Consistent high performing stocks over Five Years

Rising Net Cash Flow and Cash from Operating activity

Companies that saw improvement in net profits, operating profit margin and revenues in the most recent quarter

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Good Aggregate Candlestick Strength (total bullish - bearish candlesticks)

High Momentum Scores (Technical Scores greater than 50)

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing Revenue every quarter for the past 3 quarters

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Top Gainers

Stocks Outperforming their Industry Price Change in the Quarter

Wockhardt Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
17 Nov, 2016	10	INTERIM	19 Nov, 2016	Equity Share
13 Nov, 2014	20	INTERIM	15 Nov, 2014	Equity Share
17 Feb, 2014	5	INTERIM	19 Feb, 2014	Equity Share
07 Nov, 2013	5	INTERIM	08 Nov, 2013	Equity Share
22 Aug, 2013	5	FINAL		Equity Share
17 Apr, 2008	2.5	FINAL		Equity Share
26 Oct, 2007	8.75	INTERIM	29 Oct, 2007	Equity Share
22 Mar, 2007	5	FINAL	23 Mar, 2007	Equity Share
21 Jun, 2006	5	FINAL		Equity Share
12 Apr, 2005	5	FINAL		Equity Share

Wockhardt Stock Comparison

Financials	Rubicon Research Ltd.	Anthem Biosciences Ltd.	Sai Life Science Ltd.	Emcure Pharmaceuticals Ltd.	Mankind Pharma Ltd.	Piramal Pharma Ltd.
Price (₹)	₹1,429	₹754.95	₹1,265	₹1,805	₹2,523	₹176.50
% Change	1.55%	0.39%	2.48%	-0.25%	-0.36%	2.62%
Revenue TTM (₹ Cr)	₹1,753.96	₹2,124.33	₹2,192.49	₹9,203.54	₹14,277.64	₹8,869.07
Net Profit TTM (₹ Cr)	₹246.74	₹591.79	₹348.91	₹924.36	₹1,912.93	₹-325.93
PE TTM	94.30	71.60	75.10	37.10	54.70	-70.30
1 Year Return	190.14	31.93	57.98	43.82	0.21	-14.62
ROCE	24.32	27.56	18.38	25.65	14.32	2.29

Similar Stocks

ACUTAAS

Acutaas Chemicals Ltd.

₹ 3390.00

-1.99%

GLAND

Gland Pharma Ltd.

₹ 2475.00

+0.22%

LAURUSLABS

Laurus Labs Ltd.

₹ 1535.50

+1.86%

ALKEM

Alkem Laboratories Ltd.

₹ 5676.00

+0.49%

BIOCON

Biocon Ltd.

₹ 418.25

+3.64%

DIVISLAB

Divi's Laboratories Ltd.

₹ 6830.50

+0.26%

GRANULES

Granules India Ltd.

₹ 887.00

+0.56%

AJANTPHARM

Ajanta Pharma Ltd.

₹ 3366.00

+1.77%

ZYDUSLIFE

Zydus Lifesciences Ltd.

₹ 1152.10

-0.60%

GLENMARK

Glenmark Pharmaceuticals Ltd.

₹ 2284.50

+0.76%

AUROPHARMA

Aurobindo Pharma Ltd.

₹ 1568.90

-1.17%

SUNPHARMA

Sun Pharmaceutical Industries Ltd.

₹ 1932.90

-0.30%

NEULANDLAB

Neuland Laboratories Ltd.

₹ 19478.00

-0.33%

IPCALAB

Ipca Laboratories Ltd.

₹ 1780.10

+0.55%

JBCHEPHARM

J B Chemicals & Pharmaceuticals Ltd.

₹ 2420.00

-1.00%

ASTRAZEN

AstraZeneca Pharma India Ltd.

₹ 8115.00

+0.01%

GLAXO

GlaxoSmithKline Pharmaceuticals Ltd.

₹ 2433.00

-0.30%

PFIZER

Pfizer Ltd.

₹ 4720.00

+2.83%

ABBOTINDIA

Abbott India Ltd.

₹ 27340.00

+2.13%

TORNTPHARM

Torrent Pharmaceuticals Ltd.

₹ 4890.00

-0.17%

LUPIN

Lupin Ltd.

₹ 2496.00

-0.29%

DRREDDY

Dr. Reddy's Laboratories Ltd.

₹ 1246.90

-1.78%

CIPLA

Cipla Ltd.

₹ 1442.00

+0.05%

FAQ's on WOCKPHARMA

What is the current share price of Wockhardt Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Wockhardt Ltd. is ₹ 1812.8 on the NSE and ₹ 1815 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Wockhardt Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Wockhardt Ltd. is approximately ₹ 29757.2 Cr.

What are the PE and PB ratios for Wockhardt Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Wockhardt Ltd. is 139.7, and the Price-to-Book (PB) ratio is 6.

What is the 52-Week High and Low for Wockhardt Ltd.?

Over the past 52 weeks, the highest price reached by Wockhardt Ltd. shares was ₹ 2422.3, and the lowest price was ₹ 1086.7.

Who are the major shareholders of Wockhardt Ltd.?

Significant shareholdings in Wockhardt Ltd. typically include entities such as:

Promoter
Public
Mutual Funds
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Wockhardt Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Wockhardt Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Wockhardt Ltd.?

Wockhardt Ltd. last declared a INTERIM dividend of ₹ 10 per share for the financial period ending 2016. The record date was set as 2016-11-17, and the payment was/is scheduled around 2016-11-17. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy